Free Newsletter
Genes can increase longevity, reduce cancer risk
Researchers at UC San Francisco are focusing on a group of genes that not only influence longevity but also reduce the risk of cancer. Analysts say that their work could lead to new therapeutics that would not only extend lives but also make sure that people could live longer without getting cancer. Age and cancer are closely related. A person who is 65 is 100 times more likely than a 35-year-old to get cancer. The researchers include biologist Cynthia Kenyon, who determined in 1993 that a change in the daf-2 gene could double the life span of a C. elegans roundworm.
"This is very exciting," Kenyon said. "There is a widely held view that any mechanism that slows aging would probably stimulate tumor growth. But we found many genes that increase lifespan, but slow tumor growth. Humans have versions of many of these genes, so this work may lead to treatments that keep us youthful and cancer-free much longer than normal."
- here's the release on the research work
ALSO: Understanding how the naked mole rat can shut down its metabolism in lean times could offer insights into lengthening the lives of humans. Report
Related Articles:
Ingredient in wine may boost longevity, health. Report
Longevity gene may be key to living past 100. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: